ZYME vs NVAX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 04, 2026
ZYME
NVAX
Investment Advisor Scores
NVAX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ZYME | NVAX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 21.9298 | 2.5846 | NVAX |
| PEG Ratio | 0 | 1.3218 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -91.1% | -79.1% | NVAX |
| Earnings Growth | 0.0% | -38.1% | ZYME |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.1/100 | 56.4/100 | NVAX |
| Profit Margin | -126.3% | -14.7% | NVAX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ZYME
MarkdownPrice below a falling SMA50 (slope -3.2%), weak momentum, RSI 35
NVAX
MarkdownPrice below a falling SMA50 (slope -2.6%), weak momentum, RSI 33
Fundamentals Snapshot
| Metric | ZYME | NVAX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 26.3 | -29.1 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.9% | -0.8% |
| Gross Margin | -0.7% | 0.3% |
| Operating Margin | -19.6% | -0.1% |
| EPS | -1.37 | -0.56 |
| Dividend Yield | — | — |